SPDR® MSCI Europe Health Care UCITS ETF (EUR) | HLTHRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 3.8 | 17.5 | 1.7 | 5.1 | 7.5 | |
+/-Cat | -13.7 | 8.1 | 6.3 | 8.2 | 5.6 | |
+/-B’mrk | - | -0.7 | -4.1 | 7.6 | 2.7 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 17/05/2024 | EUR 225.35 | |
Day Change | -0.67% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 1214 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BKWQ0H23 | |
Fund Size (Mil) 17/05/2024 | EUR 672.46 | |
Share Class Size (Mil) 17/05/2024 | EUR 672.46 | |
Ongoing Charge 27/10/2023 | 0.18% |
Investment Objective: SPDR® MSCI Europe Health Care UCITS ETF (EUR) | HLTH |
The investment objective of the Fund is to track the performance of European large and midsized companies in the Health Care sector. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Ludovic Brancourt 05/12/2014 | ||
Inception Date 05/12/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Health Care 35/20 Capped NR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for SPDR® MSCI Europe Health Care UCITS ETF (EUR) | HLTH | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 24.84 |
AstraZeneca PLC | Healthcare | 13.77 |
Novartis AG Registered Shares | Healthcare | 11.71 |
Roche Holding AG | Healthcare | 9.94 |
Sanofi SA | Healthcare | 6.66 |
Increase Decrease New since last portfolio | ||
SPDR® MSCI Europe Health Care UCITS ETF (EUR) | HLTH |